The Conversion or Exercise Price of Derivative Security is 1-for-1. | The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. | The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. | Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
HAGEMANN ROBERT
Director·Direct
Grant · Acquire
Phantom Stock UnitsDerivative
Shares+875.35
Price$0.00
Total Value$0
Shares Owned After32.95K
Transaction DateMay 22, 2026
Footnotes ▸
The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. | The Conversion or Exercise Price of Derivative Security is 1-for-1. | Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. | Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. | Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Post-Transaction Holdings
HAGEMANN ROBERT
Security
Shares
Change
Phantom Stock Units
32.95K
+875.35 (2.73%)
Restricted Stock Units
25.93K
+1.52K (6.22%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-22
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK: 0001136869
--- Reporting Owner ---
Name: HAGEMANN ROBERT
CIK: 0001222676
Role: Director
--- Derivative Transactions ---
[Transaction #1]
Security: Phantom Stock Units
Date: 2026-05-22 | Code: A (Grant or award)
Shares: +875.35 | Price: $0.00
Shares Owned After: 32,952.074 | Ownership: D (Direct)
Footnotes:
[F1] The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[F2] The Conversion or Exercise Price of Derivative Security is 1-for-1.
[F3] Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
[F3] Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
[F4] Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[Transaction #2]
Security: Restricted Stock Units
Date: 2026-05-22 | Code: A (Grant or award)
Shares: +1,517.274 | Price: $0.00
Shares Owned After: 25,927 | Ownership: D (Direct)
Footnotes:
[F2] The Conversion or Exercise Price of Derivative Security is 1-for-1.
[F5] The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
[F5] The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
[F6] Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
--- Footnotes (Complete Index) ---
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
F4: Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F5: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
F6: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
--- Signature ---
/s/ /s/ Matthew R. St. Louis, Attorney-in-Fact for Robert Hagemann (power of attorney previously filed) (2026-05-27)
